|
|
Volumn 99, Issue 1, 2008, Pages 240-
|
|
β2-adrenergic receptor polymorphism and venous thromboembolism [3]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARGININE;
BETA 2 ADRENERGIC RECEPTOR;
BLOOD CLOTTING FACTOR 5 LEIDEN;
GLUTAMIC ACID;
GLUTAMINE;
GLYCINE;
AMINO ACID SUBSTITUTION;
BODY MASS;
CARDIOVASCULAR RISK;
CASE CONTROL STUDY;
CONFIDENCE INTERVAL;
DIABETES MELLITUS;
DOMINANT INHERITANCE;
GENETIC ASSOCIATION;
GENETIC POLYMORPHISM;
GENETIC RISK;
GENETIC VARIABILITY;
GENOTYPE;
HAZARD RATIO;
HIGH RISK POPULATION;
HUMAN;
INCIDENCE;
LETTER;
PRIORITY JOURNAL;
RECESSIVE INHERITANCE;
RISK FACTOR;
STATISTICAL SIGNIFICANCE;
THROMBOPHILIA;
VENOUS THROMBOEMBOLISM;
CLINICAL TRIAL;
COHORT ANALYSIS;
FEMALE;
GENE FREQUENCY;
GENETIC PREDISPOSITION;
GENETICS;
MALE;
MULTICENTER STUDY;
NOTE;
RISK;
RISK ASSESSMENT;
UNITED STATES;
COHORT STUDIES;
FEMALE;
GENE FREQUENCY;
GENETIC PREDISPOSITION TO DISEASE;
HUMANS;
MALE;
ODDS RATIO;
POLYMORPHISM, GENETIC;
RECEPTORS, ADRENERGIC, BETA-2;
RISK ASSESSMENT;
RISK FACTORS;
UNITED STATES;
VENOUS THROMBOEMBOLISM;
|
|
EID: 38349134160
PISSN: 03406245
EISSN: None
Source Type: Journal
DOI: 10.1160/TH07-08-0520 Document Type: Letter |
|
Times cited : (1)
|
|
References (4)
|
